NASA launches second phase of moon recycling competition
The space agency's LunaRecycle Challenge is looking for the brightest minds to figure out a way to recycle plastics, foams and metals left behind by ongoing activity and building in space.
"NASA is eager to see how reimagining these materials can be helpful to potential future planetary surface missions," said Jennifer Edmunson, acting program manager for Centennial Challenges at NASA's Marshall Space Flight Center in Alabama.
"I'm confident focusing on the most critical trash items -- and integration of the prototype and digital twin competition tracks -- will yield remarkable solutions," Edmunson added, "that could enable a sustainable human presence off-Earth and transform the future of space exploration."
As the United States discusses replacing the International Space Station and placing a small nuclear reactor on the moon, the potential for increased waste in space is growing.
LunaRecycle's Phase 1 competition attracted record-breaking interest with more than 1,200 registrations. Seventeen teams, from five countries and nine U.S. states, were named winners in that challenge.
For Phase 2, only U.S. individuals and teams may participate and must build a physical prototype to manage a year's worth of trash. The challenge estimates a crew of four astronauts would produce more than 4,600 pounds of single-use waste to include food packaging and discarded clothing. The goal for competitors is to recycle the waste, while minimizing crew time and any hazards.
Submissions for NASA's LunaRecycle milestone round, which is being administered by the University of Alabama, are open now and due January 2026. Finalists from that round will be announced in February with up to 20 finalists competing in the challenge's in-person prototype demonstrations next August. Successful solutions in both rounds could net winners cash prizes totaling $2 million.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TechCrunch
4 minutes ago
- TechCrunch
NASA has sparked a race to develop the data pipeline to Mars
For decades, NASA built and flew its own relay orbiters and spacecraft to ferry valuable data back to Earth. Now, the agency is shifting to buying connectivity as a service, much like it does for launch and astronaut transport. That pivot has sparked a race, with major contenders pitching ways to keep Mars missions online. What's at stake isn't a single contract: it's the data pipe to Mars. This new approach, which will mix NASA assets and commercial infrastructure, would gradually replace the patchwork relay network the agency relies on today. Generally, that works by orbiters like Mars Reconnaissance Orbiter and MAVEN that pickup data from rovers and landers, and transmit it to the Deep Space Network's (DSN) giant antennas on Earth. NASA's relay spacecraft are still healthy, but they were never meant to be a permanent backbone. The agency's latest senior review on planetary missions calls out MAVEN's critical role as a relay and provides steps to keep it available into the early 2030s. But eventually, this hardware will decay. At the same time, NASA's Space Communications and Navigation (SCaN) program, which manages the DSN, is looking for solutions to augment these aging assets. The aim, according to an RFP released in July and due today, is to create an interoperable marketplace where NASA can be one of many customers instead of the owner-operator. The current request is specifically for capability studies, not immediate hardware buys. The ask is two-fold: a 'lunar trunkline' between the Moon and Earth, and end-to-end Mars communications that move data from assets on the surface, through Mars orbit, and to operations centers on Earth. It's a formidable challenge. Any architecture must contend with the vast distance between Earth and the Moon and Mars, long latency, periodic solar interference and Earth visibility windows, and high requirements for fault-tolerant systems. That's why NASA is asking for plans, to gauge how industry might solve these puzzles, rather than immediately jumping to procurement. Techcrunch event Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $600+ before prices rise. Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. San Francisco | REGISTER NOW While TechCrunch can't confirm which companies are submitting concept proposals, a handful have already staked their place in the race. Blue Origin just unveiled a Mars Telecommunications Orbiter built on its Blue Ring platform, pitched as maneuverable, high-performance spacecraft to support NASA missions to Mars as soon as 2028. Rocket Lab has touted its own Mars telecom orbiter concept, which the company says is a core element of its proposed architecture for the Mars Sample Return campaign. In 2024, NASA's Mars Exploration Program separately funded 12 short commercial services studies, including a trio of studies for next-gen relay services, to SpaceX, Lockheed Martin, and Blue Origin. SpaceX's proposal to 'adapt Earth-orbit communication satellites for Mars' will likely be derived from its Starlink internet satellite constellation. The long-term goal is to transform the agency's planetary exploration agenda from pure-science missions to a permanent human presence on the moon and, eventually, Mars.
Forbes
4 minutes ago
- Forbes
Fei-Fei Li Challenges Silicon Valley's Obsession With AGI
Dr. Fei‑Fei Li sees AI not as a runaway superintelligent force but as a partner in human potential. Speaking with CNN's Matt Egan at the Ai4 conference in Las Vegas, she sketched a future where learning, spatial reasoning, and immersive digital worlds grow together. Empathy, curiosity, and responsibility, she said, should be the drivers. That's a very different tone from Geoffrey Hinton, who told the same audience just a day prior that our survival might one day depend on giving AI something like a mother's protective instinct. Li's focus stays on human decision-making, not on machines 'caring' for us. Reframing the Discussion of Superintelligence For Dr. Li, the quest for the superintelligent machine, or AGI, is not really separate from the concept of AI. She explained, 'I don't know the difference between the word AGI and AI. Because when Alan Turing and John McCarthy and Marvin Minsky, the founding fathers and thinkers of AI, when they dared humanity with this possibilities of machines that they can do, in my opinion, they didn't say that machines that think narrowly and non-generally. They literally just had the biggest imagination." To Li, AI isn't a race or a looming contest of strength. It's another step in building systems that work alongside people and protect the things we value. Hinton, in contrast, warns that machines could surpass human intelligence within a couple of decades and that keeping control will be nearly impossible. His proposal is to design them with an ingrained sense of care, modeled on a parent's concern for a child. However, Li doesn't think safety comes from simulating affection. For her, the safer path is to build strong oversight, good design, and values that put people first. Hinton often frames the challenge in terms of survival: keeping a powerful AI from harming or leaving us behind. Li puts her energy into making sure it improves the spaces we live and work in. Her concern is less about keeping pace with an adversary, more about shaping a collaborator. Hinton is less certain that human control will be possible at all if AI reaches superintelligence. That's why he argues for programming in care instincts from the start. Li's answer is to shape an AI's goals early, through design, oversight, and a clear sense of its role in serving people. Education as a Living Conversation Li reframed AI's role in education as an extension of the Socratic method, urging educators and parents to champion curiosity over shortcuts. Li talks about AI in classrooms the way some teachers talk about Socrates: a tool for asking questions that make you think harder. She wants students encouraged to probe and explore, not to lean on AI for quick answers. 'Prompting' in her view should be the start of an investigation, not the end of it. She pushes back against the reflexive link between AI and academic dishonesty. Too much energy, she says, goes into banning and blocking, and not enough into asking how the technology could make people better learners. Clear-Eyed About the Risks Li's optimism doesn't mean blind faith. She worries about AI being used to spread false information, the disruption of jobs, the huge amounts of energy needed to train the biggest models, and the risk that only a few benefit from gains in productivity. She doesn't think those outcomes are inevitable. They're problems to be solved starting with how we set goals, who gets to decide them, and how they're carried out. In her view, it's not enough to 'teach' AI to care. What matters is aligning its purpose with strong governance, fair access, and uses that make life better for people. That means designing from the ground up with those aims in mind. Through her startup World Labs, Li is working on what she calls 'spatial intelligence', which is AI that understands and creates three-dimensional spaces. The uses range from surgical teams working with greater precision to far-flung families celebrating together in virtual rooms. These aren't just fantasy backdrops. They're designed to improve real-world life by blending the physical and the digital in ways that feel natural. For Li, the point of technology is to give people more control over their own choices. AI, she says, should make decisions more transparent, not less. She believes everyone should keep their dignity and their right to question what they're told. Li talks about AI as a piece of global infrastructure, something that could change how we learn, create, and connect. She wants the story of this century to include the ways AI helped expand creativity, rethink education, and keep people at the center of the story, not just the ways we avoided catastrophe. Her vision casts AI as a partner in curiosity and progress, not as a ruler. It's aimed at building immersive worlds, richer conversations in classrooms, and tools that fit into human lives with respect for our choices. Dr. Li and Hinton have known each other for decades. She would agree with him on one point: intelligence, human and machine, will grow. Where they part ways is in the plan for that future. He would give AI the instincts of a caregiver. She would anchor it in the creativity, care, and shared purpose that humans bring. And she keeps coming back to the same idea: we decide how to live in the world we're building.
Fox News
12 minutes ago
- Fox News
Popular weight-loss drugs linked to sudden vision loss, research suggests
New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how semaglutide and tirzepatide — which include popular drugs like Ozempic, Wegovy, Mounjaro and Zepbound — impacted eye health in Americans with type 2 diabetes over a two-year period. One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN) – a rare eye condition that can lead to sudden vision loss due to lack of blood flow – in association with semaglutide and tirzepatide. Out of more than 159,000 study participants with type 2 diabetes, 35 developed NAION, compared to 19 people in the comparison group. The Ohio-based researchers also noted an increased risk of developing "other optic nerve disorders," identified in 93 patients. Although the second study did not observe a "statistically significant difference" in NAION in GLP-1 drug users, there was a small increase in diabetic retinopathy, an eye disease that can damage the retina. While individuals with type 2 diabetes on GLP-1s showed a modestly increased risk of diabetic retinopathy, the researchers concluded that fewer patients experienced sight-threatening complications from the disease. "These findings suggest that all patients with type 2 diabetes treated with GLP-1 RAs, regardless of preexisting diabetic retinopathy, should be regularly screened and monitored for potential complications," the study authors concluded. Sue Decotiis, M.D., a medical weight loss doctor in New York City, said she believes more studies are required to confirm the association between these drugs and vision loss, as these studies report some conflicting results. "NAION is a rare condition of the optic nerve that, although serious, has not really been shown to be increased by these studies," Decotiis, who was not involved in the research, told Fox News Digital. "We need more studies for certain." Diabetic patients already face a high incidence of eye disease related to blood flow and nerve damage, the expert noted. "Eye complications are often directly related to the degree or lack thereof of diabetes control." In most cases, GLP-1 drugs reduce the severity of type 2 diabetes, therefore reducing the incidence of eye diseases, Decotiis noted. These drugs have also been shown to reduce the risk of cardiovascular disease, like hypertension, and to improve circulation, which can improve eye health. For diabetics who are starting a GLP-1, Decotiis recommends having an exam done by an ophthalmologist and scheduling follow-up exams throughout treatment. "We should take precaution with methodical ophthalmic care for diabetics on these drugs," Decotiis said. "However, let's not throw the baby out with the bath water." For more Health articles, visit Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital. "Patient safety is a top priority for Novo Nordisk, and we take all reports about adverse events from the use of our medicines very seriously. NAION is a very rare eye disease, and it is not an adverse drug reaction for the marketed formulations of semaglutide (Ozempic, Rybelsus and Wegovy) as per the approved labels in the U.S." "Novo Nordisk, on its part, has conducted an analysis across randomized controlled clinical trials with GLP-1 receptor agonists, including a blinded ophthalmologist evaluation to confirm NAION diagnoses. Our current assessment is that these data do not suggest a causal relationship between GLP-1 RA use and NAION events."
